Special section on drug metabolism and the microbiome RNA-seq quantification of hepatic drug processing genes in germ-free mice

Drug Metabolism and Disposition

Volumn 43, Issue 10, 2015, Pages 1572-1580

  Selwyn, Felcy Pavithra ^a   Cui, Julia Yue ^a   Klaassen, Curtis D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ALDEHYDE OXIDASE; ALKALINE PHOSPHATASE; ARYLDIALKYLPHOSPHATASE; BETA GLUCURONIDASE; CARBONYL REDUCTASE; CARBOXYLESTERASE; CHOLINESTERASE; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 REDUCTASE; DRUG METABOLIZING ENZYME; EPOXIDE HYDROLASE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE P2; HYDROLASE; LIPOXYGENASE; MESSENGER RNA; METHYLTRANSFERASE; ORGANIC CATION TRANSPORTER 1; OXIDOREDUCTASE; PEPTIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PREGNANE X RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; DRUG; RNA;

ADULT; ARTICLE; CYP1A2 GENE; CYP3A11 GENE; CYP4A14 GENE; DOWN REGULATION; DRUG METABOLISM; ENZYME METABOLISM; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION; GENE TARGETING; HYDROLYSIS; INTESTINE FLORA; MALE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SEQUENCE; UPREGULATION; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENETICS; GERMFREE ANIMAL; LIVER; METABOLISM; PROCEDURES; SEQUENCE ANALYSIS;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; GERM-FREE LIFE; LIVER; MALE; MICE; MICE, INBRED C57BL; PHARMACEUTICAL PREPARATIONS; RNA; SEQUENCE ANALYSIS, RNA;

EID: 84946203976     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.115.063545     Document Type: Article

References (21)

1. Björkholm B., Bok CM, Lundin A, Rafter J., Hibberd ML, and Pettersson S (2009) Intestinal microbiota regulate xenobiotic metabolism in the liver. PLoS ONE 4:e6958.
2. Cui JY, Gunewardena SS, Yoo B, Liu J., Renaud HJ, Lu H, Zhong XB, and Klaassen CD (2012) RNA-Seq reveals different mRNA abundance of transporters and their alternative transcript isoforms during liver development. Toxicol Sci 127:592-608.
3. Goodacre R (2007) Metabolomics of a superorganism. J Nutr 137(Suppl) 259S-266S.
4. Houston JB, Day J, and Walker J (1982) Azo reduction of sulphasalazine in healthy volunteers. Br J Clin Pharmacol 14:395-398.
5. Hsu MH, Savas U, Griffin K.J., and Johnson EF (2007) Human cytochrome p450 family 4 enzymes: function, genetic variation and regulation. Drug Metab Rev 39:515-538.
6. Lindenbaum J, Rund DG, Butler V.P., Jr, Tse-Eng D, and Saha JR (1981) Inactivation of digoxin by the gut flora: reversal by antibiotic therapy. N Engl J Med 305:789-794.
7. Morgan ET (1997) Regulation of cytochromes P450 during inflammation and infection. Drug Metab Rev 29:1129-1188.
8. Renaud HJ, Cui JY, Khan M, and Klaassen CD (2011) Tissue distribution and gender-divergent expression of 78 cytochrome P450 mRNAs in mice. Toxicol Sci 124:261-277.
9. Saha JR, Butler VP, Jr, Neu HC, and Lindenbaum J (1983) Digoxin-inactivating bacteria: identification in human gut flora. Science 220:325-327.
10. Sauer J, Richter KK, and Pool-Zobel BL (2007) Products formed during fermentation of the prebiotic inulin with human gut flora enhance expression of biotransformation genes in human primary colon cells. Br J Nutr 97:928-937.
11. Shaw S and Jayatilleke E (1990) The role of aldehyde oxidase in ethanol-induced hepatic lipid peroxidation in the rat. Biochem J 268:579-583.
12. Slatter JG, Su P, Sams J.P., Schaaf LJ, and Wienkers LC (1997) Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions. Drug Metab Dispos 25:1157-1164.
13. Sousa T, Paterson R, Moore V., Carlsson A, Abrahamsson B, and Basit AW (2008) The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm 363:1-25.
14. Staudinger JL, Goodwin B, Jones S.A., Hawkins-Brown D, MacKenzie KI, LaTour A, Liu Y., Klaassen CD, Brown KK, and Reinhard J, et al. (2001) The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 98:3369-3374.
15. Stein J, Schröder O, Bonk M., Oremek G, Lorenz M, and Caspary WF (1996) Induction of glutathione-S-transferase-pi by short-chain fatty acids in the intestinal cell line Caco-2. Eur J Clin Invest 26:84-87.
16. Stojančević M, Bojić G, Salami HA, and Mikov M (2013) The influence of intestinal tract and probiotics on the fate of orally administered drugs. Curr Issues Mol Biol 16:55-68.
17. Toda T, Saito N, Ikarashi N., Ito K, Yamamoto M, Ishige A., Watanabe K, and Sugiyama K (2009) Intestinal flora induces the expression of Cyp3a in the mouse liver. Xenobiotica 39: 323-334.
18. Ueyama J, Nadai M, Kanazawa H., Iwase M, Nakayama H, Hashimoto K., Yokoi T, Baba K, Takagi K., and Takagi K, et al. (2005) Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters. Eur J Pharmacol 510:127-134.
19. Xie HJ, Broberg U, Griskevicius L., Lundgren S, Carlens S, Meurling L., Paul C, Rane A, and Hassan M (2003) Alteration of pharmacokinetics of cyclophosphamide and suppression of the cytochrome p450 genes by ciprofloxacin. Bone Marrow Transplant 31:197-203.
20. Zhang L, Nichols RG, Correll J, Murray I.A., Tanaka N., Smith P, Hubbard TD, Sebastian A, Albert I., and Hatzakis E, et al. (2015) Persistent organic pollutants modify gut microbiota-host metabolic homeostasis in mice through aryl hydrocarbon receptor activation. Environ Health Perspect DOI: 10.1289/ehp.1409055 [published ahead of print].
21. Zhang YK, Yeager RL, and Klaassen CD (2009) Circadian expression profiles of drug-processing genes and transcription factors in mouse liver. Drug Metab Dispos 37:106-115.